These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 30972640)
21. Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial. Pai N; Popov J BMJ Open; 2017 Aug; 7(8):e016698. PubMed ID: 28827258 [TBL] [Abstract][Full Text] [Related]
22. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis. Narula N; Kassam Z; Yuan Y; Colombel JF; Ponsioen C; Reinisch W; Moayyedi P Inflamm Bowel Dis; 2017 Oct; 23(10):1702-1709. PubMed ID: 28906291 [TBL] [Abstract][Full Text] [Related]
24. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study). Sood A; Singh A; Mahajan R; Midha V; Mehta V; Gupta YK; Narang V; Kaur K J Gastroenterol Hepatol; 2020 Mar; 35(3):418-424. PubMed ID: 31408913 [TBL] [Abstract][Full Text] [Related]
25. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665 [TBL] [Abstract][Full Text] [Related]
26. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583 [TBL] [Abstract][Full Text] [Related]
27. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Shi Y; Dong Y; Huang W; Zhu D; Mao H; Su P PLoS One; 2016; 11(6):e0157259. PubMed ID: 27295210 [TBL] [Abstract][Full Text] [Related]
28. Colonic transendoscopic tube-delivered enteral therapy (with video): a prospective study. Zhang T; Long C; Cui B; Buch H; Wen Q; Li Q; Ding X; Ji G; Zhang F BMC Gastroenterol; 2020 May; 20(1):135. PubMed ID: 32375675 [TBL] [Abstract][Full Text] [Related]
29. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. Crothers JW; Chu ND; Nguyen LTT; Phillips M; Collins C; Fortner K; Del Rio-Guerra R; Lavoie B; Callas P; Velez M; Cohn A; Elliott RJ; Wong WF; Vo E; Wilcox R; Smith M; Kassam Z; Budd R; Alm EJ; Mawe GM; Moses PL BMC Gastroenterol; 2021 Jul; 21(1):281. PubMed ID: 34238227 [TBL] [Abstract][Full Text] [Related]
30. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis. Zhang L; Ma X; Liu P; Ge W; Hu L; Zuo Z; Xiao H; Liao W Exp Biol Med (Maywood); 2021 Jul; 246(13):1563-1575. PubMed ID: 33926254 [TBL] [Abstract][Full Text] [Related]
31. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638 [TBL] [Abstract][Full Text] [Related]
32. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Schierová D; Březina J; Mrázek J; Fliegerová KO; Kvasnová S; Bajer L; Drastich P Cells; 2020 Oct; 9(10):. PubMed ID: 33066233 [TBL] [Abstract][Full Text] [Related]
35. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis. Singh A; Mahajan R; Kahlon BK; Dhaliwal AS; Midha V; Mehta V; Bansal N; Singh D; Sood A Indian J Gastroenterol; 2022 Aug; 41(4):389-396. PubMed ID: 36121613 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis. Zhao HL; Chen SZ; Xu HM; Zhou YL; He J; Huang HL; Xu J; Nie YQ J Dig Dis; 2020 Oct; 21(10):534-548. PubMed ID: 33439534 [TBL] [Abstract][Full Text] [Related]
37. Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Zhou HY; Guo B; Lufumpa E; Li XM; Chen LH; Meng X; Li BZ Immunol Invest; 2021 May; 50(4):323-337. PubMed ID: 32009472 [TBL] [Abstract][Full Text] [Related]
38. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Lu G; Wang W; Li P; Wen Q; Cui B; Zhang F Microb Biotechnol; 2022 Sep; 15(9):2439-2449. PubMed ID: 35576458 [TBL] [Abstract][Full Text] [Related]
39. Fecal microbiota transplantation through transendoscopic enteral tubing for inflammatory bowel disease: High acceptance and high satisfaction. Lin J; Xiong J; Jin Y; Wang H; Wu L; Chen L; Zhang F; Ji G; Cui B J Gastroenterol Hepatol; 2024 Feb; 39(2):328-336. PubMed ID: 38016701 [TBL] [Abstract][Full Text] [Related]
40. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Angelberger S; Reinisch W; Makristathis A; Lichtenberger C; Dejaco C; Papay P; Novacek G; Trauner M; Loy A; Berry D Am J Gastroenterol; 2013 Oct; 108(10):1620-30. PubMed ID: 24060759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]